TABLE 3.
Strain | Plasmid | β-Galactosidase activity (Miller units)a
|
β-Galactosidase/total proteins (%)b
|
% of Lac+ coloniesc
|
|||
---|---|---|---|---|---|---|---|
−2OHB | +2OHB | −2OHB | +2OHB | −2OHB | +2OHB | ||
CC118λpir | pTPm-lacZ | 1,211 | 1,358 | NDd | ND | 100 | 100 |
CC118λpir | pCNB2-lacZ | 10,917 | 67,002 | 3.6 | 13 | 98, 81 | 20, 1.5 |
CC118λpir | pCNB4-lacZ | 510 | 17,952 | ND | 3.9 | 100, 97 | 96, 85 |
CC4S2PT32 | 171 | 30,383 | ND | 8.8 | 100 | 100 | |
CC4S2PT97 | 408 | 39,143 | ND | 11 | 100 | 100 | |
CC1184S2λpir | pTPm-lacZ | 1,487 | 78,257 | ND | 20 | 100, 99 | 5, 0 |
β-Galactosidase activity was assayed after 5 h of incubation without salicylate (−2OHB) or with 2 mM salicylate (+2OHB). The data are means from three independent experiments.
The relative amounts of β-galactosidase in cells were measured by densitometry of Coomassie blue-stained SDS-8% PAGE gels.
The stability assay was performed as described in Materials and Methods. Three independent experiments were performed for each strain and type of conditions. As expected, the values varied considerably for the experiments with the plasmid-containing strains, probably due to the stochastic appearance of the cured strains during culture. The maximum and minimum values are shown except for cases when identical results were obtained.
ND, not determined (0.5%).